|
Volumn 104, Issue 1-2, 1984, Pages 9-18
|
Cardiovascular characterisation of UL-FS 49,1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylimino]propyl]-2H-3-benzazepin- 2-on hydrochloride, a new "specific bradycardic agent"
|
Author keywords
AQ A 39; Isolated atria; Sinus bradycardia; Specific bradycardic agent; UL FS 49
|
Indexed keywords
ATROPINE;
CARBACHOL;
DILTIAZEM;
FALIPAMIL;
HYDRALAZINE;
MEXILETINE;
NEW DRUG;
NIFEDIPINE;
NORADRENALIN;
SOTALOL;
VERAPAMIL;
VERAPAMIL DERIVATIVE;
ZATEBRADINE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTICHOLINERGIC EFFECT;
CARDIOVASCULAR SYSTEM;
CAT;
DOG;
DRUG EFFICACY;
DRUG INTERACTION;
GUINEA PIG;
HEART;
HEART VENTRICLE REPOLARIZATION;
NONHUMAN;
RABBIT;
RAT;
SINUS BRADYCARDIA;
ANIMAL;
AORTA, THORACIC;
BENZAZEPINES;
BLOOD PRESSURE;
CARDIOVASCULAR AGENTS;
CATS;
DOGS;
ELECTRIC STIMULATION;
ELECTROCARDIOGRAPHY;
FEMALE;
GUINEA PIGS;
HEART RATE;
HEMODYNAMICS;
IN VITRO;
MALE;
MUSCLE, SMOOTH, VASCULAR;
MYOCARDIAL CONTRACTION;
PARASYMPATHOLYTICS;
PHTHALIMIDES;
POTASSIUM;
RABBITS;
|
EID: 0021175617
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/0014-2999(84)90363-7 Document Type: Article |
Times cited : (80)
|
References (21)
|